1.90
Finanzdaten der Enveric Biosciences Inc-Aktie (ENVB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
307.58%
0.000274
|
-0.000132 | 0.000002 | -0.000225 | -0.000217 |
|
|
25.59%
1.8742
|
2.5189 | 2.1875 | 3.1736 | 2.083 |
| Benefits Costs and Expenses |
25.61%
1.8739
|
2.519 | 2.185 | 3.1472 | 2.0838 |
| Costs And Expenses |
25.61%
1.8739
|
2.519 | 2.185 | 3.1472 | 2.0838 |
| Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
| Depreciation and Amortization |
0.97%
0.0404
|
0.04 | 0.081 | 0.0825 | 0.0848 |
| Operating Income/Loss |
25.61%
-1.8739
|
-2.519 | -2.1875 | -3.1738 | -2.0832 |
| Net Interest Income/Expense |
307.58%
0.000274
|
-0.000132 | 0.000002 | -0.000225 | -0.000217 |
| Nonoperating Income/Loss |
307.58%
0.000274
|
-0.000132 | 0.00257 | 0.0264 | -0.00084 |
| Income/Loss From Continuing Operations Before Tax |
25.62%
-1.8737
|
-2.5192 | -2.185 | -3.1474 | -2.084 |
| Income/Loss From Continuing Operations After Tax |
25.62%
-1.8737
|
-2.5192 | -2.185 | -3.1564 | -2.084 |
|
|
25.62%
-1.8737
|
-2.5192 | -2.185 | -3.1546 | -2.084 |
| Preferred Stock Dividends And Other Adjustments |
1.5134
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
87.93%
0.3132
|
2.5957 | 1.7978 | -6.2683 | 8.703 |
| Diluted Average Shares |
87.93%
0.3132
|
2.5957 | 1.7978 | -6.2683 | 8.703 |
| Basic Earnings Per Share |
1,014%
-10.81
|
-0.97 | -1.22 | -18.09 | -0.24 |
| Diluted Earnings Per Share |
1,014%
-10.81
|
-0.97 | -1.22 | -18.09 | -0.24 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
1.5134
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):